We used beads coated with anti-PSMA antibodies to capture a fraction of urinary PSMA-positive EVs according to protocol described by Mizutani et al.47 that enabled successful immunocapture of EVs from plasma of prostate cancer patient. The gene discussed is FOLH1; the disease is prostate carcinoma.